Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease

Volume: 10
Published: Oct 22, 2020
Abstract
Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant neoplasms, further subcategorized in over 20 histological subtypes. For the most part, treatment for advanced disease is guided by morphology. SGC in general respond poorly to standard chemotherapy, with short durability and significant toxicity. More recently, next-generation sequencing provided significant input on the molecular characterization of each SGC...
Paper Details
Title
Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
Published Date
Oct 22, 2020
Volume
10
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.